Logo image of ONC

BEONE MEDICINES LTD-ADR (ONC) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ONC - US07725L1026 - ADR

318.69 USD
-7.8 (-2.39%)
Last: 12/9/2025, 8:21:59 PM
318.69 USD
0 (0%)
After Hours: 12/9/2025, 8:21:59 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ONC revenue by date.ONC revenue by date.
9.566B
26.06%
17.423B
82.13%
27.214B
56.19%
37.927B
39.37%
46.287B
22.04%
53.541B
15.67%
59.16B
10.49%
65.808B
11.24%
73.454B
11.62%
78.522B
6.90%
86.194B
9.77%
EBITDA
YoY % growth
ONC ebitda by date.ONC ebitda by date.
N/A
-38.91%
N/A
26.94%
N/A
56.75%
3.953B
213.93%
7.238B
83.10%
10.731B
48.26%
22.05B
105.48%
32.747B
48.51%
39.667B
21.13%
45.733B
15.29%
30.173B
-34.02%
EBIT
YoY % growth
ONC ebit by date.ONC ebit by date.
-12.026B
-27.00%
-8.751B
27.23%
-4.242B
51.53%
2.704B
163.75%
5.729B
111.87%
8.2B
43.13%
14.71B
79.39%
17.905B
21.72%
22.919B
28.00%
25.463B
11.10%
28.212B
10.80%
Operating Margin
ONC operating margin by date.ONC operating margin by date.
-125.71%-50.22%-15.59%7.13%12.38%15.32%24.86%27.21%31.20%32.43%32.73%
EPS
YoY % growth
ONC eps by date.ONC eps by date.
-141.14
45.69%
-64.31
54.44%
-50.47
21.52%
19.70
139.04%
46.26
134.77%
72.46
56.66%
1,294.28
1,686.08%
1,430.43
10.52%
1,854.16
29.62%
1,728.76
-6.76%
2,248.29
30.05%

All data in CNY

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25
EPS
Q2Q % growth
10.08
-96.79%
Revenue
Q2Q % growth
10.959B
38.58%
EBITDA
Q2Q % growth
1.822B
EBIT
Q2Q % growth
1.382B
336.13%

All data in CNY

Recent Earnings VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
7.94
188.84%
8.40-0.46-5.45%
Q2 2025
Q2Q % growth
5.41
104.68%
0.424.991,187.13%
Q1 2025
Q2Q % growth
124.55
151.87%
-4.14128.693,109.85%
Q4 2024
Q2Q % growth
314.05
1,260.99%
16.52297.531,800.57%
Q3 2024
Q2Q % growth
-8.94
-159.34%
-7.28-1.66-22.81%
Q2 2024
Q2Q % growth
-115.45
-323.98%
-12.74-102.71-805.99%
Q1 2024
Q2Q % growth
-240.13
-856.85%
-21.85-218.28-999.20%
Q4 2023
Q2Q % growth
-27.05
18.03%
-11.48-15.57-135.57%
Q3 2023
Q2Q % growth
15.07
138.68%
-26.3341.40157.25%
Q2 2023
Q2Q % growth
-27.23
30.85%
-25.21-2.02-8.03%
Q1 2023
Q2Q % growth
-25.10
15.81%
-24.79-0.31-1.25%
Q4 2022
Q2Q % growth
-33.00
25.20%
-13.16-19.84-150.68%
Q3 2022
Q2Q % growth
-38.96 -39.070.110.28%
Q2 2022
Q2Q % growth
-39.38 -30.81-8.57-27.81%
Q1 2022
Q2Q % growth
-29.81 -26.47-3.34-12.63%
Q4 2021
Q2Q % growth
-44.12 -35.29-8.83-25.02%
ONC Yearly EPS VS EstimatesONC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 500 1K 1.5K 2K
Recent Revenue VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
10.108B
40.84%
10.247B-139.487M-1.36%
Q2 2025
Q2Q % growth
9.47B
40.76%
8.91B560.399M6.29%
Q1 2025
Q2Q % growth
8.074B
50.65%
8.176B-102.423M-1.25%
Q4 2024
Q2Q % growth
7.908B
73.88%
7.496B412.084M5.50%
Q3 2024
Q2Q % growth
7.176B
27.60%
7.158B18.363M0.26%
Q2 2024
Q2Q % growth
6.728B
60.77%
5.255B1.473B28.03%
Q1 2024
Q2Q % growth
5.359B
74.78%
4.557B802.338M17.61%
Q4 2023
Q2Q % growth
4.548B
68.60%
4.07B478.108M11.75%
Q3 2023
Q2Q % growth
5.624B
111.55%
4.108B1.516B36.90%
Q2 2023
Q2Q % growth
4.185B
84.97%
3.256B928.839M28.53%
Q1 2023
Q2Q % growth
3.066B
57.42%
2.897B169.389M5.85%
Q4 2022
Q2Q % growth
2.698B
98.00%
2.44B257.639M10.56%
Q3 2022
Q2Q % growth
2.659B
99.05%
2.406B252.516M10.50%
Q2 2022
Q2Q % growth
2.262B
135.16%
2.048B214.396M10.47%
Q1 2022
Q2Q % growth
1.948B
-50.42%
1.838B109.858M5.98%
Q4 2021
Q2Q % growth
1.362B
105.94%
1.413B-50.562M-3.58%
Q3 2021
Q2Q % growth
1.336B
-8.44%
%
ONC Yearly Revenue VS EstimatesONC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20B 40B 60B 80B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1.13% 6.22% 35.08% 93.22%
Revenue0% 0.03% 0.76% 2.03%